General Information of This Drug (ID: DMEXWWV)

Drug Name
Bromhexine   DMEXWWV
Synonyms
Bromhexine hydrochloride; 611-75-6; Bromhexine HCl; Auxit; Bromohexine hydrochloride; Viscolyt; Bisolvon; Broncokin; Bromhexine chloride; Quentan; UNII-YC2ZOM3Z8V; Bromhexine (hydrochloride); Bromohexine monohydrochloride; 2,4-Dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrochloride; YC2ZOM3Z8V; CHEBI:31303; NCGC00095005-01; AK163668; N-(2-Amino-3,5-dibromobenzyl)-N-methyl-cyclohexylammonium chloride; 2-Amino-3,5-dibromo-N-cyclohexyl-N-methylbenzylamine hydrochloride
Indication
Disease Entry ICD 11 Status REF
Sjogren syndrome 4A43.20 Approved [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
Bromhexine + Ruxolitinib DCNPQ8P Ruxolitinib Hodgkin lymphoma (Cell Line: L-1236) [2]
------------------------------------------------------------------------------------
2 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Bromhexine + Hydroxychloroquine DCCDYTY Hydroxychloroquine Hydroxychloroquine [3]
Bromhexine + Hydroxychloroquine DCWHDEZ Hydroxychloroquine Coronavirus Disease 2019 (COVID-19) [4]
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
3 ClinicalTrials.gov (NCT04340349) Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals
4 Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia